Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Obesity | Research

Association of sleep duration with sarcopenic obesity in multi-ethnic older adults: findings from the WCHAT Study

Authors: Mei Yang, Yan Zhang, Wan-yu Zhao, Mei-ling Ge, Xue-lian Sun, Shu-li Jia, Bi-rong Dong

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Objective

Sarcopenic obesity is a prevalent geriatric syndrome, characterized by concurrence of sarcopenia and obesity. Sleep duration is linked to both obesity and sarcopenia. However, little was known regarding the association of sleep duration with sarcopenic obesity. In this study, we aimed to examine the association of sleep duration with sarcopenic obesity in multi-ethnic community-dwelling older adults.

Methods

Sarcopenia was defined according to the criteria established by Asian Working Group for Sarcopenia (AWGS) 2019. Obesity was defined as body fat percentage above the 60th percentile specified by sex. Sarcopenic obesity was defined as concurrence of obesity and sarcopenia. Sleep duration was collected by a self-reported questionnaire and was further divided into 5 groups: “<6 h”, “6–7 h”, “7–8 h”, “8–9 h” (reference group) and “≥9 h” (long sleep). Logistic regressions were adopted to examine the association.

Results

2256 multi-ethnic adults aged 60 and over from the West China Health and Aging Trend (WCHAT) study were involved for present study. Overall, 6.25% of the participants were classified as sarcopenic obesity. In the fully adjusted model, long sleep duration (≥ 9 h) was significantly associated with sarcopenic obesity compared with reference group (OR = 1.81, 95%CI = 1.10–2.98, P = 0.019). However, in subgroup analysis, this association can only be observed in male (OR 1.98, 95% CI = 1.02–3.87, P = 0.043) not in female (OR = 1.83, 95%CI = 0.85–3.94, P = 0.118). Regarding ethnic difference, Han older adults with long sleep duration (≥ 9 h) presented increased risk of sarcopenic obesity while ethnic minorities did not.

Conclusion

This study disclosed that long sleep duration significantly increased the risk of sarcopenic obesity among older adults. And our findings highlight the critical role of assessing sleep duration to identify individuals at risk of sarcopenic obesity.
Literature
1.
go back to reference Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, et al. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–35.CrossRefPubMedPubMedCentral Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, et al. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–35.CrossRefPubMedPubMedCentral
2.
go back to reference Donini LM, Busetto L, Bauer JM, Bischoff S, Boirie Y, Cederholm T, Cruz-Jentoft AJ, Dicker D, Fruhbeck G, Giustina A, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020;39(8):2368–88.CrossRefPubMed Donini LM, Busetto L, Bauer JM, Bischoff S, Boirie Y, Cederholm T, Cruz-Jentoft AJ, Dicker D, Fruhbeck G, Giustina A, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020;39(8):2368–88.CrossRefPubMed
3.
go back to reference Guillet C, Masgrau A, Walrand S, Boirie Y. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obes Rev. 2012;13(Suppl 2):51–7.CrossRefPubMed Guillet C, Masgrau A, Walrand S, Boirie Y. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obes Rev. 2012;13(Suppl 2):51–7.CrossRefPubMed
4.
go back to reference Hirani V, Naganathan V, Blyth F, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ, Cumming RG. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. Age Ageing. 2017;46(3):413–20.CrossRefPubMed Hirani V, Naganathan V, Blyth F, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ, Cumming RG. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project. Age Ageing. 2017;46(3):413–20.CrossRefPubMed
5.
go back to reference Gandham A, Mesinovic J, Jansons P, Zengin A, Bonham MP, Ebeling PR, Scott D. Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: A systematic review and meta-analysis. Obes Rev. 2021;22(5):e13187.CrossRefPubMed Gandham A, Mesinovic J, Jansons P, Zengin A, Bonham MP, Ebeling PR, Scott D. Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: A systematic review and meta-analysis. Obes Rev. 2021;22(5):e13187.CrossRefPubMed
6.
go back to reference Evans K, Abdelhafiz D, Abdelhafiz AH. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review. Postgrad Med. 2021;133(8):831–42.CrossRefPubMed Evans K, Abdelhafiz D, Abdelhafiz AH. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: a systematic review. Postgrad Med. 2021;133(8):831–42.CrossRefPubMed
7.
go back to reference Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y, Deng R, Cheng ASK: Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr 2019, 19(1):183. Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y, Deng R, Cheng ASK: Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr 2019, 19(1):183.
8.
go back to reference Agostini F, Bernetti A, Di Giacomo G, Viva MG, Paoloni M, Mangone M, Santilli V, Masiero S. Rehabilitative Good Practices in the Treatment of Sarcopenia: A Narrative Review. Am J Phys Med Rehabil. 2021;100(3):280–7.CrossRefPubMed Agostini F, Bernetti A, Di Giacomo G, Viva MG, Paoloni M, Mangone M, Santilli V, Masiero S. Rehabilitative Good Practices in the Treatment of Sarcopenia: A Narrative Review. Am J Phys Med Rehabil. 2021;100(3):280–7.CrossRefPubMed
9.
go back to reference de Sire A, Ferrillo M, Lippi L, Agostini F, de Sire R, Ferrara PE, Raguso G, Riso S, Roccuzzo A, Ronconi G, et al: Sarcopenic Dysphagia, Malnutrition, and Oral Frailty in Elderly: A Comprehensive Review. Nutrients 2022, 14(5). de Sire A, Ferrillo M, Lippi L, Agostini F, de Sire R, Ferrara PE, Raguso G, Riso S, Roccuzzo A, Ronconi G, et al: Sarcopenic Dysphagia, Malnutrition, and Oral Frailty in Elderly: A Comprehensive Review. Nutrients 2022, 14(5).
10.
go back to reference de Sire A, Baricich A, Reno F, Cisari C, Fusco N, Invernizzi M. Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study. Aging Clin Exp Res. 2020;32(5):959–62.CrossRefPubMed de Sire A, Baricich A, Reno F, Cisari C, Fusco N, Invernizzi M. Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study. Aging Clin Exp Res. 2020;32(5):959–62.CrossRefPubMed
11.
go back to reference Avola M, Mangano GRA, Testa G, Mangano S, Vescio A, Pavone V, Vecchio M. Rehabilitation Strategies for Patients with Femoral Neck Fractures in Sarcopenia: A Narrative Review. J Clin Med 2020, 9(10). Avola M, Mangano GRA, Testa G, Mangano S, Vescio A, Pavone V, Vecchio M. Rehabilitation Strategies for Patients with Femoral Neck Fractures in Sarcopenia: A Narrative Review. J Clin Med 2020, 9(10).
12.
go back to reference Hsu KJ, Liao CD, Tsai MW, Chen CN. Effects of Exercise and Nutritional Intervention on Body Composition, Metabolic Health, and Physical Performance in Adults with Sarcopenic Obesity: A Meta-Analysis. Nutrients 2019, 11(9). Hsu KJ, Liao CD, Tsai MW, Chen CN. Effects of Exercise and Nutritional Intervention on Body Composition, Metabolic Health, and Physical Performance in Adults with Sarcopenic Obesity: A Meta-Analysis. Nutrients 2019, 11(9).
13.
go back to reference Koliaki C, Liatis S, Dalamaga M, Kokkinos A. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives. Curr Obes Rep. 2019;8(4):458–71.CrossRefPubMed Koliaki C, Liatis S, Dalamaga M, Kokkinos A. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives. Curr Obes Rep. 2019;8(4):458–71.CrossRefPubMed
14.
go back to reference Fan Y, Zhang L, Wang Y, Li C, Zhang B, He J, Guo P, Qi X, Zhang M, Guo C, et al. Gender differences in the association between sleep duration and body mass index, percentage of body fat and visceral fat area among chinese adults: a cross-sectional study. BMC Endocr Disord. 2021;21(1):247.CrossRefPubMedPubMedCentral Fan Y, Zhang L, Wang Y, Li C, Zhang B, He J, Guo P, Qi X, Zhang M, Guo C, et al. Gender differences in the association between sleep duration and body mass index, percentage of body fat and visceral fat area among chinese adults: a cross-sectional study. BMC Endocr Disord. 2021;21(1):247.CrossRefPubMedPubMedCentral
15.
go back to reference Li Q: The association between sleep duration and excess body weight of the American adult population: a cross-sectional study of the national health and nutrition examination survey 2015–2016. BMC public health 2021, 21(1):335. Li Q: The association between sleep duration and excess body weight of the American adult population: a cross-sectional study of the national health and nutrition examination survey 2015–2016. BMC public health 2021, 21(1):335.
16.
17.
go back to reference Liu H, Chen G, Wen J, Wang A, Mu Y, Dou J, Gu W, Zang L, Zhang S, Lyu Z. Association between sleep duration and incidence of type 2 diabetes in China: the REACTION study. Chin Med J (Engl) 2022. Liu H, Chen G, Wen J, Wang A, Mu Y, Dou J, Gu W, Zang L, Zhang S, Lyu Z. Association between sleep duration and incidence of type 2 diabetes in China: the REACTION study. Chin Med J (Engl) 2022.
18.
go back to reference Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92.CrossRefPubMed Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92.CrossRefPubMed
19.
go back to reference Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585–92.CrossRefPubMedPubMedCentral Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585–92.CrossRefPubMedPubMedCentral
20.
go back to reference Chien MY, Wang LY, Chen HC. The Relationship of Sleep Duration with Obesity and Sarcopenia in Community-Dwelling Older Adults. Gerontology. 2015;61(5):399–406.CrossRefPubMed Chien MY, Wang LY, Chen HC. The Relationship of Sleep Duration with Obesity and Sarcopenia in Community-Dwelling Older Adults. Gerontology. 2015;61(5):399–406.CrossRefPubMed
21.
go back to reference Kwon YJ, Jang SY, Park EC, Cho AR, Shim JY, Linton JA. Long Sleep Duration is Associated With Sarcopenia in Korean Adults Based on Data from the 2008–2011 KNHANES. J Clin Sleep Med. 2017;13(9):1097–104.CrossRefPubMedPubMedCentral Kwon YJ, Jang SY, Park EC, Cho AR, Shim JY, Linton JA. Long Sleep Duration is Associated With Sarcopenia in Korean Adults Based on Data from the 2008–2011 KNHANES. J Clin Sleep Med. 2017;13(9):1097–104.CrossRefPubMedPubMedCentral
22.
go back to reference Kim RH, Kim KI, Kim JH, Park YS. Association between Sleep Duration and Body Composition Measures in Korean Adults: The Korea National Health and Nutrition Examination Survey 2010. Korean J Fam Med. 2018;39(4):219–24.CrossRefPubMedPubMedCentral Kim RH, Kim KI, Kim JH, Park YS. Association between Sleep Duration and Body Composition Measures in Korean Adults: The Korea National Health and Nutrition Examination Survey 2010. Korean J Fam Med. 2018;39(4):219–24.CrossRefPubMedPubMedCentral
23.
go back to reference Hou L, Liu X, Zhang Y, Zhao W, Xia X, Chen X, Lin X, Yue J, Ge N, Dong B. Cohort Profile: West China Health and Aging Trend (WCHAT). J Nutr Health Aging. 2021;25(3):302–10.CrossRefPubMed Hou L, Liu X, Zhang Y, Zhao W, Xia X, Chen X, Lin X, Yue J, Ge N, Dong B. Cohort Profile: West China Health and Aging Trend (WCHAT). J Nutr Health Aging. 2021;25(3):302–10.CrossRefPubMed
24.
go back to reference Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, Hazen N, Herman J, Katz ES, Kheirandish-Gozal L, et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40–3.CrossRefPubMed Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, Hazen N, Herman J, Katz ES, Kheirandish-Gozal L, et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40–3.CrossRefPubMed
25.
go back to reference Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–7 e302.CrossRefPubMed Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–7 e302.CrossRefPubMed
26.
go back to reference Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr. 2009;89(6):1895–900.CrossRefPubMed Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr. 2009;89(6):1895–900.CrossRefPubMed
27.
go back to reference Zhang L, Wang C, Sha SY, Kwauk S, Miller AR, Xie MS, Dong YQ, Kong QQ, Wu LJ, Zhang FZ, et al. Mini-nutrition assessment, malnutrition, and postoperative complications in elderly Chinese patients with lung cancer. J BUON. 2012;17(2):323–6.PubMed Zhang L, Wang C, Sha SY, Kwauk S, Miller AR, Xie MS, Dong YQ, Kong QQ, Wu LJ, Zhang FZ, et al. Mini-nutrition assessment, malnutrition, and postoperative complications in elderly Chinese patients with lung cancer. J BUON. 2012;17(2):323–6.PubMed
28.
go back to reference Conway JM, Irwin ML, Ainsworth BE. Estimating energy expenditure from the Minnesota Leisure Time Physical Activity and Tecumseh Occupational Activity questionnaires - a doubly labeled water validation. J Clin Epidemiol. 2002;55(4):392–9.CrossRefPubMed Conway JM, Irwin ML, Ainsworth BE. Estimating energy expenditure from the Minnesota Leisure Time Physical Activity and Tecumseh Occupational Activity questionnaires - a doubly labeled water validation. J Clin Epidemiol. 2002;55(4):392–9.CrossRefPubMed
29.
go back to reference Pourmotabbed A, Ghaedi E, Babaei A, Mohammadi H, Khazaie H, Jalili C, Symonds ME, Moradi S, Miraghajani M: Sleep duration and sarcopenia risk: a systematic review and dose-response meta-analysis. Sleep Breath 2020, 24(4):1267–1278. Pourmotabbed A, Ghaedi E, Babaei A, Mohammadi H, Khazaie H, Jalili C, Symonds ME, Moradi S, Miraghajani M: Sleep duration and sarcopenia risk: a systematic review and dose-response meta-analysis. Sleep Breath 2020, 24(4):1267–1278.
30.
go back to reference Nakakubo S, Doi T, Tsutsumimoto K, Kurita S, Ishii H, Shimada H. Sleep duration and progression to sarcopenia in Japanese community-dwelling older adults: a 4 year longitudinal study. J Cachexia Sarcopenia Muscle. 2021;12(4):1034–41.CrossRefPubMedPubMedCentral Nakakubo S, Doi T, Tsutsumimoto K, Kurita S, Ishii H, Shimada H. Sleep duration and progression to sarcopenia in Japanese community-dwelling older adults: a 4 year longitudinal study. J Cachexia Sarcopenia Muscle. 2021;12(4):1034–41.CrossRefPubMedPubMedCentral
31.
go back to reference Wu Y, Zhai L, Zhang D. Sleep duration and obesity among adults: a meta-analysis of prospective studies. Sleep Med. 2014;15(12):1456–62.CrossRefPubMed Wu Y, Zhai L, Zhang D. Sleep duration and obesity among adults: a meta-analysis of prospective studies. Sleep Med. 2014;15(12):1456–62.CrossRefPubMed
32.
go back to reference Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Med Rev. 2018;39:25–36.CrossRefPubMed Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Med Rev. 2018;39:25–36.CrossRefPubMed
33.
go back to reference Brady EM, Bodicoat DH, Hall AP, Khunti K, Yates T, Edwardson C, Davies MJ. Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes. Diabetes Res Clin Pract. 2018;139:195–202.CrossRefPubMed Brady EM, Bodicoat DH, Hall AP, Khunti K, Yates T, Edwardson C, Davies MJ. Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes. Diabetes Res Clin Pract. 2018;139:195–202.CrossRefPubMed
34.
35.
go back to reference Lam CS, Chen MH, Lacey SM, Yang Q, Sullivan LM, Xanthakis V, Safa R, Smith HM, Peng X, Sawyer DB, et al. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol. 2010;30(7):1479–84.CrossRefPubMedPubMedCentral Lam CS, Chen MH, Lacey SM, Yang Q, Sullivan LM, Xanthakis V, Safa R, Smith HM, Peng X, Sawyer DB, et al. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol. 2010;30(7):1479–84.CrossRefPubMedPubMedCentral
36.
go back to reference Piovezan RD, Abucham J, Dos Santos RV, Mello MT, Tufik S, Poyares D. The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing Res Rev. 2015;23(Pt B):210–20.CrossRefPubMed Piovezan RD, Abucham J, Dos Santos RV, Mello MT, Tufik S, Poyares D. The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing Res Rev. 2015;23(Pt B):210–20.CrossRefPubMed
37.
go back to reference Wang T. Searching for the link between inflammaging and sarcopenia. Ageing Res Rev. 2022;77:101611.CrossRefPubMed Wang T. Searching for the link between inflammaging and sarcopenia. Ageing Res Rev. 2022;77:101611.CrossRefPubMed
38.
go back to reference Chiba I, Lee S, Bae S, Makino K, Shinkai Y, Katayama O, Harada K, Takayanagi N, Shimada H. Difference in sarcopenia characteristics associated with physical activity and disability incidences in older adults. J Cachexia Sarcopenia Muscle. 2021;12(6):1983–94.CrossRefPubMedPubMedCentral Chiba I, Lee S, Bae S, Makino K, Shinkai Y, Katayama O, Harada K, Takayanagi N, Shimada H. Difference in sarcopenia characteristics associated with physical activity and disability incidences in older adults. J Cachexia Sarcopenia Muscle. 2021;12(6):1983–94.CrossRefPubMedPubMedCentral
40.
go back to reference Bellavia A, Akerstedt T, Bottai M, Wolk A, Orsini N. Sleep duration and survival percentiles across categories of physical activity. Am J Epidemiol. 2014;179(4):484–91.CrossRefPubMed Bellavia A, Akerstedt T, Bottai M, Wolk A, Orsini N. Sleep duration and survival percentiles across categories of physical activity. Am J Epidemiol. 2014;179(4):484–91.CrossRefPubMed
41.
go back to reference Savin KL, Patel SR, Clark TL, Bravin JI, Roesch SC, Sotres-Alvarez D, Mossavar-Rahmani Y, Evenson KR, Daviglus M, Ramos AR, et al. Relationships of Sleep Duration, Midpoint, and Variability with Physical Activity in the HCHS/SOL Sueno Ancillary Study. Behav Sleep Med. 2021;19(5):577–88.CrossRefPubMed Savin KL, Patel SR, Clark TL, Bravin JI, Roesch SC, Sotres-Alvarez D, Mossavar-Rahmani Y, Evenson KR, Daviglus M, Ramos AR, et al. Relationships of Sleep Duration, Midpoint, and Variability with Physical Activity in the HCHS/SOL Sueno Ancillary Study. Behav Sleep Med. 2021;19(5):577–88.CrossRefPubMed
42.
go back to reference Pettee Gabriel K, Sternfeld B, Shiroma EJ, Perez A, Cheung J, Lee IM. Bidirectional associations of accelerometer-determined sedentary behavior and physical activity with reported time in bed: Women’s Health Study. Sleep Health. 2017;3(1):49–55.CrossRefPubMed Pettee Gabriel K, Sternfeld B, Shiroma EJ, Perez A, Cheung J, Lee IM. Bidirectional associations of accelerometer-determined sedentary behavior and physical activity with reported time in bed: Women’s Health Study. Sleep Health. 2017;3(1):49–55.CrossRefPubMed
43.
go back to reference Tan X, Chapman CD, Cedernaes J, Benedict C. Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanisms. Sleep Med Rev. 2018;40:127–34.CrossRefPubMed Tan X, Chapman CD, Cedernaes J, Benedict C. Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanisms. Sleep Med Rev. 2018;40:127–34.CrossRefPubMed
44.
go back to reference Harfmann BD, Schroder EA, Esser KA. Circadian rhythms, the molecular clock, and skeletal muscle. J Biol Rhythms. 2015;30(2):84–94.CrossRefPubMed Harfmann BD, Schroder EA, Esser KA. Circadian rhythms, the molecular clock, and skeletal muscle. J Biol Rhythms. 2015;30(2):84–94.CrossRefPubMed
45.
go back to reference Li Y, Ma J, Yao K, Su W, Tan B, Wu X, Huang X, Li T, Yin Y, Tosini G, et al. Circadian rhythms and obesity: Timekeeping governs lipid metabolism. J Pineal Res. 2020;69(3):e12682.CrossRefPubMed Li Y, Ma J, Yao K, Su W, Tan B, Wu X, Huang X, Li T, Yin Y, Tosini G, et al. Circadian rhythms and obesity: Timekeeping governs lipid metabolism. J Pineal Res. 2020;69(3):e12682.CrossRefPubMed
47.
go back to reference Choi Y, Cho J, No MH, Heo JW, Cho EJ, Chang E, Park DH, Kang JH, Kwak HB. Re-Setting the Circadian Clock Using Exercise against Sarcopenia. Int J Mol Sci 2020, 21(9). Choi Y, Cho J, No MH, Heo JW, Cho EJ, Chang E, Park DH, Kang JH, Kwak HB. Re-Setting the Circadian Clock Using Exercise against Sarcopenia. Int J Mol Sci 2020, 21(9).
48.
go back to reference Gabriel BM, Zierath JR. Circadian rhythms and exercise - re-setting the clock in metabolic disease. Nat Rev Endocrinol. 2019;15(4):197–206.CrossRefPubMed Gabriel BM, Zierath JR. Circadian rhythms and exercise - re-setting the clock in metabolic disease. Nat Rev Endocrinol. 2019;15(4):197–206.CrossRefPubMed
Metadata
Title
Association of sleep duration with sarcopenic obesity in multi-ethnic older adults: findings from the WCHAT Study
Authors
Mei Yang
Yan Zhang
Wan-yu Zhao
Mei-ling Ge
Xue-lian Sun
Shu-li Jia
Bi-rong Dong
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03543-0

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine